Success Metrics

Clinical Success Rate
88.7%

Based on 110 completed trials

Completion Rate
89%(110/124)
Active Trials
24(13%)
Results Posted
35%(38 trials)
Terminated
14(8%)

Phase Distribution

Ph early_phase_1
11
6%
Ph phase_2
31
17%
Ph phase_1
23
13%
Ph phase_3
19
10%
Ph phase_4
54
30%
Ph not_applicable
32
17%

Phase Distribution

34

Early Stage

31

Mid Stage

73

Late Stage

Phase Distribution170 total trials
Early Phase 1First-in-human
11(6.5%)
Phase 1Safety & dosage
23(13.5%)
Phase 2Efficacy & side effects
31(18.2%)
Phase 3Large-scale testing
19(11.2%)
Phase 4Post-market surveillance
54(31.8%)
N/ANon-phased studies
32(18.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.9%

110 of 128 finished

Non-Completion Rate

14.1%

18 ended early

Currently Active

24

trials recruiting

Total Trials

183

all time

Status Distribution
Active(29)
Completed(110)
Terminated(18)
Other(26)

Detailed Status

Completed110
unknown26
Recruiting19
Terminated14
Active, not recruiting5
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
183
Active
24
Success Rate
88.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 111 (6.5%)
Phase 123 (13.5%)
Phase 231 (18.2%)
Phase 319 (11.2%)
Phase 454 (31.8%)
N/A32 (18.8%)

Trials by Status

active_not_recruiting53%
enrolling_by_invitation11%
unknown2614%
not_yet_recruiting42%
withdrawn42%
recruiting1910%
terminated148%
completed11060%

Recent Activity

Clinical Trials (183)

Showing 20 of 183 trialsScroll for more
NCT03525873Phase 3

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

Active Not Recruiting
NCT05561205Not Applicable

rTMS for Apathy Clinical Trial

Recruiting
NCT05630781Not Applicable

Orexin s Role in the Neurobiology of Substance Use Disorder

Recruiting
NCT07314333Phase 1

A Trial to Assess How Centanafadine Interacts With Stimulants in the Body

Recruiting
NCT01410942Phase 2

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

Active Not Recruiting
NCT07301632Phase 2

Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial

Recruiting
NCT03511118

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting
NCT03652740Phase 1

Effects of Commonly Used Medications on Mood and Choice

Completed
NCT05776056Phase 4

Methylphenidate for the Treatment of PTSD With Associated Neurocognitive Complaints

Recruiting
NCT02879136Early Phase 1

TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease

Completed
NCT03280251Phase 2

Methylphenidate and Cognitive Training in Elderly

Completed
NCT06081179Phase 1

Does Serotonin System Stimulation Increase Pro-social Behavior? - A Comparative Pharmacological Neuroscientific Study in Healthy Humans

Completed
NCT05474846Phase 2

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Recruiting
NCT04501653Early Phase 1

Precision Functional Brain Mapping in Psilocybin

Completed
NCT03814356Phase 1

Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness

Active Not Recruiting
NCT05761756Not Applicable

Oxygen Toxicity: Mechanisms in Humans

Recruiting
NCT04781972Phase 4

Multimodal Brain Imaging of the Neural Effects of Methylphenidate in Patients With ADHD

Recruiting
NCT06355414Phase 1

Psilocybin in Chronic Low Back Pain and Depression

Recruiting
NCT03772834Phase 2

Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer

Active Not Recruiting
NCT05978167Early Phase 1

Targeting Drug Memories With Methylphenidate

Active Not Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
183